Skip to content
PICO Portalanswers from OpenAlex

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer

PaperCitations, authors & open-access status

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer is a paper indexed in PICO Portal from OpenAlex.

How many citations does Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer have?

PICO Portalcitation count

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer has 1,834 citations in the OpenAlex counts PICO Portal stores.

When was Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer published?

PICO Portalyear

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer has 2005 year in the PICO Portal index.

What is the open-access status of Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer?

PICO Portaloa status

Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer has bronze oa status in the PICO Portal index.

What is the DOI of Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer?

PICO Portaldoi

The DOI for Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer is on the source record.

What is the PMID of Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer?

PICO Portalpmid

The PMID for Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer is on the source record.

What is the OpenAlex record for Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer?

PICO Portalopenalex

The OpenAlex for Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial